I

Inovio Pharmaceuticals

D
INO
USD
0.02
(0.3617%)
Market Closed
2,314.00
Volume
-4.64
EPS
-
Div Yield
-1.094675
P/E
144,101,687.40
Market Cap
Today
0.3617%
1 Week
1.648%
1 Month
-2.546%
6 Months
-49.591%
12 Months
24.629%
Year To Date
-9.314%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
I
INO
0.02
(0.3617%)
USD
A
APTX
(%)
USD
S
SRPT
1.23
(1.0218%)
USD
A
AMRN
-0.0047
(-0.8127%)
USD
A
AXSM
-0.515
(-0.568%)
USD
V
VKTX
-0.39
(-0.5664%)
USD
A
ARWR
0.515
(2.4082%)
USD
C
CRSP
-0.35
(-0.6742%)
USD
E
EDIT
-0.05
(-1.5773%)
USD
V
VCEL
4.025
(8.0444%)
USD

Title:
Inovio Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Do you need help or have a question?
Contact Us